Publications by authors named "Hitoshi Hamashima"

Claim this Profile
D
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
Kouji Hattori, Susumu Toda, Masashi Imanishi, Shinji Itou, Yutaka Nakajima, Hitoshi Hamashima

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
Yutaka Nakajima, Masashi Imanishi, Shinji Itou, Hitoshi Hamashima, Yasuyo Tomishima

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
Masashi Imanishi, Yutaka Nakajima, Yasuyo Tomishima, Hitoshi Hamashima, Kenichi Washizuka

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.
Masashi Imanishi, Shinji Itou, Kenichi Washizuka, Hitoshi Hamashima, Yutaka Nakajima

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
Masashi Imanishi, Yasuyo Tomishima, Shinji Itou, Hitoshi Hamashima, Yutaka Nakajima

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.
Yutaka Nakajima, Hitoshi Hamashima, Ken-Ichi Washizuka, Yasuyo Tomishima, Hiroaki Ohtake

Bioorg Med Chem Lett· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis